402 related articles for article (PubMed ID: 18059331)
1. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
[TBL] [Abstract][Full Text] [Related]
2. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
3. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
4. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice.
Brideau G; Mäkinen MJ; Elamaa H; Tu H; Nilsson G; Alitalo K; Pihlajaniemi T; Heljasvaara R
Cancer Res; 2007 Dec; 67(24):11528-35. PubMed ID: 18089781
[TBL] [Abstract][Full Text] [Related]
5. From tumor lymphangiogenesis to lymphvascular niche.
Hirakawa S
Cancer Sci; 2009 Jun; 100(6):983-9. PubMed ID: 19385973
[TBL] [Abstract][Full Text] [Related]
6. Tumor lymphangiogenesis and melanoma metastasis.
Rinderknecht M; Detmar M
J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
[TBL] [Abstract][Full Text] [Related]
7. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
8. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
Tobler NE; Detmar M
J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
[TBL] [Abstract][Full Text] [Related]
9. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.
Hirakawa S; Kodama S; Kunstfeld R; Kajiya K; Brown LF; Detmar M
J Exp Med; 2005 Apr; 201(7):1089-99. PubMed ID: 15809353
[TBL] [Abstract][Full Text] [Related]
10. Insights into the mechanisms of lymph node metastasis.
Nathanson SD
Cancer; 2003 Jul; 98(2):413-23. PubMed ID: 12872364
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
Iwata C; Kano MR; Komuro A; Oka M; Kiyono K; Johansson E; Morishita Y; Yashiro M; Hirakawa K; Kaminishi M; Miyazono K
Cancer Res; 2007 Nov; 67(21):10181-9. PubMed ID: 17974958
[TBL] [Abstract][Full Text] [Related]
13. Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors.
Honkanen HK; Izzi V; Petäistö T; Holopainen T; Harjunen V; Pihlajaniemi T; Alitalo K; Heljasvaara R
Neoplasia; 2016 Jul; 18(7):436-46. PubMed ID: 27435926
[TBL] [Abstract][Full Text] [Related]
14. Lymphangiogenesis and tumor metastasis.
Pepper MS; Tille JC; Nisato R; Skobe M
Cell Tissue Res; 2003 Oct; 314(1):167-77. PubMed ID: 12883995
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis.
Lee AS; Kim DH; Lee JE; Jung YJ; Kang KP; Lee S; Park SK; Kwak JY; Lee SY; Lim ST; Sung MJ; Yoon SR; Kim W
Cancer Res; 2011 Jul; 71(13):4506-17. PubMed ID: 21586615
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.
Harrell MI; Iritani BM; Ruddell A
Am J Pathol; 2007 Feb; 170(2):774-86. PubMed ID: 17255343
[TBL] [Abstract][Full Text] [Related]
17. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
[TBL] [Abstract][Full Text] [Related]
18. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
Russell JL; Weaks RL; Berton TR; Johnson DG
Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
[TBL] [Abstract][Full Text] [Related]
19. Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.
Crnic I; Strittmatter K; Cavallaro U; Kopfstein L; Jussila L; Alitalo K; Christofori G
Cancer Res; 2004 Dec; 64(23):8630-8. PubMed ID: 15574770
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis and lymphangiogenesis of skin cancers.
Dadras SS; Detmar M
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1059-70, viii. PubMed ID: 15474335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]